Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
Format: article
Langue:EN
Publié: Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2021
Sujets:
|contrast-enhanced ultrasound|hepatocellular carcinoma|transarterial radioembolization|transarterial chemoembolization|treatment response
Medical technology
R855-855.5
Medicine
R
Accès en ligne:https://doaj.org/article/1eb063ed83bc4dde8db81afc1a651394
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/1eb063ed83bc4dde8db81afc1a651394

Documents similaires